Healthcare >> CEO Interviews >> May 13, 2003
ANDREW MEADOW is a General Partner of Healthcon Corp. Mr. Meadow
concentrated the last 14 years in a variety of senior management
roles, the focus of which was to craft opportunities, define
appropriate strategies, valuing the financial implications
underpinning what products can and should be launched, and
creating decisive analytical and quantitative approaches that
help monetize business plans and launch cutting edge technologies
and therapies. In conjunction with his financial due diligence
and corporate valuation efforts, Mr. Meadow has been an advocate
of using innovative quantitative methods to ascertain the risk
profile of a transaction, including how real option and
probability analysis can assist management in mitigating the risk
associated with some transactions. Prior to HealthCon, Mr. Meadow
worked for Essex Woodlands Health Care Ventures in evaluating
private equity/venture technology opportunities within the
healthcare services, diagnostics and device arenas. Prior to this
experience, Mr. Meadow served as the Manager for Baxter
International's Corporate Business Development Team. At Baxter,
he evaluated multiple biotechnology ventures as well as emerging
treatments and products for joint venture, acquisition,
technology transfer, new product development and licensing
opportunities within the oncology, tissue engineering, cell and
gene therapy, and bioscience arenas. Before Baxter, Mr. Meadow
served on UBS Warburg's Global Healthcare Investment Banking Team
where he worked on a significant number of M&A, high-yield debt,
private placement, follow-on, and IPO transactions within the
healthcare industry. Mr. Meadow completed his MBA in Health Care
Finance and Strategy at Case Western Reserve University's
Weatherhead School of Management where he was a recipient of the
Weatherhead Merit Scholarship. In addition, Mr. Meadow has
completed Advanced Master's degree studies in Health Care and
International Economics at the Rotterdam School of Management's
Erasmus University. Before embarking upon his career, Mr. Meadow
graduated with honors and academic distinction from Franklin and
Marshall College, where he was a four year varsity letterman in
three different sports. Prior to completing his MBA, Mr. Meadow
worked for nine years in Central and Eastern Europe in a variety
of executive level positions in the areas of product development,
corporate restructuring, treasury and financial control. During
his tenure in Europe, Mr. Meadow gained extensive operational
experience in managing early stage health and consumer goods
concerns throughout Central and Eastern Europe. Mr. Meadow is
fluent in Polish and Russian. Profile
TWST: What do you see as HealthCon Corp.'s business and missiontoday?
Mr. Meadow: HealthCon's business model brings a unique
combination of industry expertise, scientific acumen and
extensive